Gene dose of apolipoprotein E and age-related hearing loss |
| |
Authors: | Kurniawan Clara Westendorp Rudi G J de Craen Anton J M Gussekloo Jacobijn de Laat Jan van Exel Eric |
| |
Institution: | EMGO Institute for Health and Care Research and Department of Psychiatry, VU University Medical Center/GGZ InGeest, Amsterdam, The Netherlands. |
| |
Abstract: | Next to outer hair cell dysfunction, age-related hearing loss may be explained by apolipoprotein E (APOE) genotype. In the Leiden 85-plus Study, a population-based study, the participants were 85 years old. We measured hearing loss by pure-tone audiometry in 435 participants in relation to APOE. Results demonstrated that those with the APOE-ε4/ε4 genotype had the highest levels of hearing loss (n = 6; 56.1 dB), those with the APOE-ε3/ε4 or ε2/ε4 genotype (n = 89) had intermediate levels of hearing loss (51.0 dB), and those without the APOE-ε4 allele (n = 340) had the lowest levels of hearing loss (48.9 dB), p for trend = 0.02. Eighty percent of participants had hearing loss of 35 dB and more, that is, hearing impairment. The APOE-ε4 allele was associated with a 2.0-fold increased risk of hearing impairment (confidence interval CI 95%], 1.0-4.0), compared with those without the APOE-ε4 allele. The risk for hearing impairment in subjects with the APOE-ε4 allele remained similar after adjustment for cardiovascular disease, stroke, and cognitive impairment. Our results suggest that the APOE-ε4 allele contributes to age-related hearing loss. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|